2021 American Transplant Congress

TOPIC: Clinical Science » Infectious Disease » Non-Organ Specific: Viral Hepatitis

Outcomes of Kidney Transplantation from Hepatitis C Virus (HCV) Infected Donors Stratified by Recipient HCV Serostatus: A Mate Kidney Analysis
K. K. Sureshkumar¹, B. Chopra¹, R. L. McGill²
Outcomes of Short-Duration Anti-Viral Prophylaxis for Hepatitis C Positive Donor Kidney Transplants
G. Gupta, I. Yakubu, P. Kimball, L. Kang, K. Mitchell, M. Shinbashi, D. Kumar, I. Moinuddin, L. Kamal, A. King, C. Bhati, M. Levy, A. Cotterell, A. Sharma, R. Sterling
Prevalence of Hepatitis E Virus Infection in Solid Organ Transplant Recipients: A Systematic Review and Meta-analysis
P. Hansrivijit¹, A. Trongtorsak², B. Boonpheng³, C. Thongprayoon⁴, W. Cheungpasitporn⁴
Processes to Successfully Utilize Hepatitis C (HCV) Infected Donor Kidneys as Standard of Care
A. Dao¹, A. Reyad¹, J. Guiteau¹, M. Madhrira², S. Allam²
Successful Single-Center Experience Using HCV+ Organs for Single and Dual-Organ Transplantation
S. Aslam, C. Logan, N. Law, J. Kerr, J. Kozuch, V. Ajmera, K. Afshar, A. Khan, E. Adler, K. Mekeel, E. Golts, V. Pretorius
Transplantation of Hepatitis C Positive Kidney and Pancreas Allografts Into Hepatitis C Naïve Recipients – A Single Center Experience as a Standard of Care
K. Yadav¹, A. Padiyar², K. Zhao³, J. Rabets³, A. Jittirat², S. Sclair⁴
Transplanting Hepatitis C Infected Organs Into Uninfected Recipients: A Pharmacy Perspective
M. L. Holt, A. James, K. Gutierrez, T. Sparkman, J. Banbury, D. Jones
Use of Donor Blood Expedites HCV Genotyping and Allows Earlier DAA Initiation for Recipients of HCV+ Kidneys
B. Lonze, N. Ali, R. Montgomery, Z. Stewart Lewis